Skip to content

A Drug Absorption Study of MK-3475A in Participants with Solid Tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505340-19-00
Acronym
MK-3475A-C18
Enrollment
34
Registered
2023-10-11
Start date
2021-09-20
Completion date
2024-09-19
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or Metastatic Solid Tumors

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Hungary, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026